Search Within

Qing Ye

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (10)
Groups
  1. Breast Medicine Service (25)
  2. Department of Medicine (25)
  3. GSK Faculty (25)
  4. Human Oncology and Pathogenesis Program (25)
  5. Molecular Pharmacology and Chemistry Program Faculty (25)
  6. Sloan Kettering Institute Faculty (25)

More Groups

People
  1. Neal Rosen (25)
  2. David Solit (21)
  3. Qing-Bai She (14)
  4. Sarat Chandarlapaty (8)
  5. Ayana Sawai (6)
  6. Jose Lobo (6)

More People

Years
  1. 2012 (1)
  2. 2010 (3)
  3. 2009 (3)
  4. 2008 (4)
  5. 2007 (2)
  6. 2006 (6)

More Years

Publications
  1. Cancer Research (11)
  2. EJC Supplements (3)
  3. Cancer Cell (2)
  4. Clinical Cancer Research (2)
  5. Journal of Clinical Oncology (2)
  6. Proceedings of the National Academy of Sciences of the United States of America (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. Pergamon-Elsevier Science Ltd (3)
  3. American Society of Clinical Oncology (2)
  4. Cell Press (2)
  5. National Academy of Sciences (2)
  6. Nature Publishing Group (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase - Dependent cancers
    Journal Article

    Chandarlapaty, S.; Sawai, A.; Ye, Q.; Scott, A.; Silinski, M.; Huang, K.; Fadden, P.; Partdrige, J.; Hall, S.; Steed, P.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Scaltriti, M.; Baselga, J.; Ye, Q.; Solit, D.; Norton, L.; Rosen, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The PI3K/AKT and MAPK signaling cooperate to mediate translational initiation and cell survival in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Zhen, W.; Solit, D.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of P13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 function downregulates EGFR and sensitizes EGFR-mutant xenografts to paclitaxel
    Meeting Abstract

    Sawai, A.; Greulich, H.; Ye, Q.; Sellers, W.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • BRAF mutation predicts sensitivity to MEK inhibition
    Journal Article

    Solit, D. B.; Garraway, L. A.; Pratilas, C. A.; Sawai, A.; Getz, G.; Basso, A.; Ye, Q.; Lobo, J. M.; She, Y.; Osman, I.; more...
    Nature (2006)

    Fulltext@MSK | Save
  • V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
    Journal Article

    Grbovic, O. M.; Basso, A. D.; Sawai, A.; Ye, Q.; Friedlander, P.; Solit, D.; Rosen, N.
    Proceedings of the National Academy of Sciences of the United States of America (2006)

    Fulltext@MSK | Save
  • Combined inhibition of PI3 kinase and EGFR overcomes the intrinsic apoptosis resistance of PTEN-null cancer cells and suppresses their xenograft growth
    Meeting Abstract

    She, Q. B.; Solit, D.; Ye, Q.; O'reilly, K.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save